Analyst Ratings for Halozyme Therapeutics (halo) [Sells]
halo Rating Summary
halo Price Target Summary
- Highest: $59.00 (Morgan Stanley)
- Lowest: $40.00 (Goldman Sachs)
- Average: $49.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.57 (+31.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
Avg. $ Target:
$49.57 (+31.1%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 78%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/2/2012 | Jefferies » Updated 8/11/2020 |
Eun Yang | Downgrade | Underperform (Hold) |
14.00 (13.00) |
8.56 (37.81) |
341.71% | Details |
